Meet the Resilient Healthcare Coalition Members
The Coalition’s Steering Committee Members represent a diverse group of stakeholders within the health sector, including industry, researchers, and advocacy groups, all across both the private and not-for-profit sectors.
Angela Behboodi
Angela Behboodi is the Director of Government Affairs and Advocacy at Amgen Canada. She has extensive experience in the biopharmaceutical industry, working for 5 years as Director of Policy at Roche Canada. Prior to that, Angela served as a federal public servant for eleven years. Learn more about Amgen Canada here.
Dr. Siân Bevan
Dr. Siân Bevan is The Arthritis Society’s Chief Science Officer responsible for driving the scientific research, advocacy, public policy and programs and services agenda to maximize reach and impact. Siân completed her PhD in Medical Biophysics. Learn more about the Arthritis Society here.
Louise Binder
Louise Binder is a Health Policy Consultant at Save Your Skin Foundation. She is a lawyer and health advocate who is involved in informing the development of health policy and systemic treatment access practices from the patient perspective. She co-founded the Canadian Treatment Action Council (CTAC) in 1996. Learn more about Save Your Skin here.
Connie Côté
Connie Côté is the Chief Executive Officer of the member-based organization Health Charities Coalition of Canada. Connie has extensive experience in the health sector, coming to HCCC from the Canadian Lung Association, where she served as Senior Director. Learn more about Health Charities Coalition of Canada here.
Nicole DeKort
Nicole DeKort is President & CEO of MedTech Canada. Nicole has a 15 year background in politics and government in a diverse portfolio of roles, including as Executive Director of Strategic Planning for the then Minister of Health and Long-Term Care. Learn more about MedTech Canada here.
Dr. Jason Field
Dr. Jason Field is the President and CEO of Life Sciences Ontario, the industry voice for the life sciences sector in Ontario. Jason obtained his PhD in Chemistry from the University of Massachusetts , and then worked in the pharmaceutical industry and for the Government of Ontario. Learn more about Life Sciences Ontario here.
Jon Feairs
Jon Feairs is the Director, Government Affairs and Public Policy at AstraZeneca Canada. Jon has over 15 years experience in public policy decision making through senior advisor roles to Ontario Cabinet Ministers and biopharmaceutical CEOs. With a degree in biochemistry, he has always been interested in the intersection of life sciences and politics. Learn more about AstraZeneca Canada here.
Ryan Lock
Ryan Lock is Director, Federal Affairs, Policy and Public Health for GSK Canada. Leading a small team within GSK’s Government Affairs and Market Access department, Ryan is responsible for developing GSK policy positions on market access and reimbursement issues and implementing evidence -driven national advocacy campaigns. Ryan is responsible for ensuring public access to GSK’s innovative vaccines portfolio in Canada. Learn more about GSK Canada here.
Jonathan Mitchell
Jonathan Mitchell is Vice-President, Research and Policy, at HealthCareCAN. He has over 15 years experience in various roles, at the Canadian Agency for Drugs and Technologies in Health (CADTH), Accreditation Canada, and the Canadian Institute for Health Information. Learn more about HealthCareCAN here.
Barry Stein
Barry D. Stein, B.Com., B.C.L., LL.B. is the President and CEO of Colorectal Cancer Canada. He actively represents the interests of cancer patients and speaks regularly to medical professionals, industry, government, and patient groups across Canada and internationally. Learn more about Colorectal Cancer Canada here.
Carlene Todd
Carlene Todd is the Vice President of Access at Roche Canada. She has extensive access experience over the past 20 years at Roche, leading the Market Access & Public Policy team at Roche Australia from 2012-2019. She was also a member of the association Medicines Australia. Learn more about Roche Canada here.
Eva Villalba
Eva Villalba is the Executive Director of the Coalition Priorité Cancer au Québec. Since 2008, she has been involved in health-care charities, advocacy groups and nonprofits. She holds an MBA from HEC Montréal and completed an MSc in 2021.. in Health Care Transformation at the UT Austin - Value Institute for Health & Care. Learn more about Coalition Priorité Cancer au Québec here.